Trials / Completed
CompletedNCT00805480
Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis
Phase II Randomized, Double-blind, Multi-center, Parallel-group, Placebo-controlled Multiple-loading Dose Regimen Study to Assess the Safety, Efficacy and Duration of Response of AIN457 in Patients With Chronic Plaque-type Psoriasis.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Loading dose, four arm, double-blind, parallel group, placebo-controlled study comparing single and multiple doses of AIN457 to placebo in patients with a diagnosis of moderate to severe chronic plaque psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AIN457 | AIN457 was administered intravenously. |
| DRUG | Placebo | Matching placebo to AIN457 was administered intravenously. |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2008-12-09
- Last updated
- 2015-02-10
- Results posted
- 2015-02-10
Source: ClinicalTrials.gov record NCT00805480. Inclusion in this directory is not an endorsement.